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Proteomic profiling of neuronal
mitochondria reveals modulators of
synaptic architecture
Laura C. Graham1,2, Samantha L. Eaton1,2, Paula J. Brunton1, Abdelmadjid Atrih3, Colin Smith2,4, Douglas J. Lamont3,
Thomas H. Gillingwater2,5, Giuseppa Pennetta2,5, Paul Skehel2,5 and Thomas M. Wishart1,2*
Abstract
Background: Neurons are highly polarized cells consisting of three distinct functional domains: the cell body (and
associated dendrites), the axon and the synapse. Previously, it was believed that the clinical phenotypes of
neurodegenerative diseases were caused by the loss of entire neurons, however it has recently become apparent that
these neuronal sub-compartments can degenerate independently, with synapses being particularly vulnerable to a broad
range of stimuli. Whilst the properties governing the differential degenerative mechanisms remain unknown, mitochondria
consistently appear in the literature, suggesting these somewhat promiscuous organelles may play a role in affecting
synaptic stability. Synaptic and non-synaptic mitochondrial subpools are known to have different enzymatic properties
(first demonstrated by Lai et al., 1977). However, the molecular basis underpinning these alterations, and their effects
on morphology, has not been well documented.
Methods: The current study has employed electron microscopy, label-free proteomics and in silico analyses to characterize
the morphological and biochemical properties of discrete sub-populations of mitochondria. The physiological relevance of
these findings was confirmed in-vivo using a molecular genetic approach at the Drosophila neuromuscular junction.
Results: Here, we demonstrate that mitochondria at the synaptic terminal are indeed morphologically different to
non-synaptic mitochondria, in both rodents and human patients. Furthermore, generation of proteomic profiles
reveals distinct molecular fingerprints – highlighting that the properties of complex I may represent an important
specialisation of synaptic mitochondria. Evidence also suggests that at least 30% of the mitochondrial enzymatic
activity differences previously reported can be accounted for by protein abundance. Finally, we demonstrate that
the molecular differences between discrete mitochondrial sub-populations are capable of selectively influencing
synaptic morphology in-vivo. We offer several novel mitochondrial candidates that have the propensity to
significantly alter the synaptic architecture in-vivo.
Conclusions: Our study demonstrates discrete proteomic profiles exist dependent upon mitochondrial subcellular
localization and selective alteration of intrinsic mitochondrial proteins alters synaptic morphology in-vivo.
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Background
Ageing is a fundamental risk factor for the development
of a large range of neurodegenerative diseases, which
are characterized by the selective death of neuronal
subpopulations [1, 2]. Neurons are highly polarized
cells consisting of three distinct functional domains:
the cell body, axon and the synapse. Previously, it was
believed that the clinical phenotypes of neurodegenerative
diseases were caused by the loss of entire neurons [3],
however it has recently become apparent that these neur-
onal sub-compartments can degenerate independently of
one another [4, 5], with synapses being particularly vulner-
able to a broad range of stimuli. Whilst the properties of
the potential differential degenerative mechanisms remain
largely unknown, numerous themes have consistently ap-
peared in the literature, suggesting that proteins regulating
the ubiquitin-proteasome system [6–8], oxidative stress
[9–12] and mitochondria [1, 6, 10, 12–15] may all play a
role in regulating the stability of the synaptic compartment.
Synaptic compartments constantly demand ATP to
maintain ionic gradients and neurotransmission events
[16]. In addition synapses also demonstrate a substantial
need for calcium buffering machinery [13]. Accordingly,
sub-populations of mitochondria are enriched pre- and
post-synaptically [1, 6, 10]. Such synaptic mitochondria are
reportedly distinguishable from non-synaptic mitochondria,
displaying unique enzymatic [17], calcium buffering [18,
19] and antioxidant properties [10]. However, if and how
these distinctive subpopulations of synaptic mitochondria
influence the vulnerability of synaptic compartments re-
mains largely unknown.
In an attempt to address this, we have used label-free
proteomics to characterise the proteomes of synaptic and
non-synaptic mitochondria following established bio-
chemical isolation methods [17]. By utilizing this method-
ology, we have generated proteomic profiles that reveal
consistent molecular fingerprints for synaptic and non-
synaptic mitochondria. Quantitative fluorescent western
blotting was used to confirm these proteomic and frac-
tionation data in a range of species, including rat and
ovine tissues. These results were consistent with the exist-
ence of distinct mitochondrial sub-populations containing
patterns of relative protein abundances that are conserved
between different mammalian species. To determine if the
molecular differences between these mitochondrial sub-
populations may be capable of influencing the vulnerabil-
ity of synapses, we manipulated the expression of
mitochondrial candidates in vivo to assess synaptic stabil-
ity in the Drosophila neuromuscular system. Our data
demonstrate that selective knock-down of intrinsic mito-
chondrial proteins identified in this manner have the po-
tential to alter synaptic morphology and the area of the
presynaptic active zone in vivo. Thus, changes in mito-
chondrial protein expression may contribute to increased
synaptic vulnerability and dysfunctional neurotransmis-
sion in early molecular pathological processes during age-
ing and/or disease.
Methods
Ethics
In line with the 3Rs no animals were bred or sacrificed
specifically for this project.
Rats
Nine male wild-type Sprague Dawley rats aged ca. 24 weeks
(actual range 168-171 days) were used. Rats were group
housed (3-4 per cage) in a SPF facility in open-top cages
and maintained on a 12-12 h light-dark cycle (lights on at
07:00 h), under controlled temperature (22 ± 2 °C) and hu-
midity (55 ± 5%) with free access to drinking water and
standard 14% protein rodent diet (Harlan Teklad). Rats
were killed by conscious decapitation and brains were imme-
diately excised. Brain stem and cerebellum were removed
and discarded. Fresh forebrains were weighed and pooled for
homogenization before mitochondrial preparations.
Sheep
Three Scottish blackface female sheep aged 5 years were
utilized. Sheep were sacrificed at the Farm Animal
Teaching Hospital, Royal (Dick) School of Veterinary
Studies, University of Edinburgh by anaesthetisation and
exsanguination. Brains were excised, bisected at the sa-
gittal midline and the brain stem and cerebellum were
removed and discarded. Tissues were submerged in ice
cold high magnesium artificial cerebral spinal fluid (NaCl
125 mM; NaHCO3 26 mM; glucose 25 mM; KCl 2.5 mM;
NaH2PO4(2H2O) 1.25 mM; CaCl2 1 mM; MgCl2 4 mM)
to maintain brain structural integrity before cortical mito-
chondrial preparations.
Mitochondrial preparations
Methodology comprehensively reported in Lai et al. [17]
was employed to produce proteomic data comparable to
early biochemical reports. All procedures were carried out
at 4 °C. Forebrains were homogenized by hand in isolation
medium (0.32 M sucrose, 1 mM K-EDTA, 10 mM, Tris
HCl) to give a 1:10 homogenate. The homogenate was
centrifuged at 1300 g for 3 min and the resulting pellet
was manually resuspended in 15 ml isolation medium be-
fore recentrifugation as before. Supernatants were pooled
and centrifuged at 17,000 g for 10 min to give the crude
mitochondrial pellet (CM). The CM pellet was resus-
pended in 15 ml isolation medium and 5 ml of the sus-
pension was layered into 3 tubes containing 7 ml of 7.5%
Ficoll-sucrose medium (7% Ficoll, 0.32 M sucrose, 50 μM
K-EDTA, 10 mM Tris HCl) on top of 7 ml of 10% Ficoll-
sucrose medium (10% Ficoll, 0.32 M sucrose, 50 μM K-
EDTA, 10 mM Tris HCl) and centrifuged at 99,000 g for
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30 min on a swing- out Beckman ultracentrifuge. This re-
sulted in a myelin (My) fraction banded at the top, a synap-
tosomal (Syn) fraction at the second interphase and a ‘free’
(non-synaptic) mitochondrial pellet (M) at the bottom of the
tube. The myelin fraction was aspirated and the synaptic
fraction collected, without disturbing the pellet. This was
then diluted in 3× isolation medium and centrifuged at
18,500 g for 10 min. The non-synaptic mitochondrial pellet
was frozen immediately on dry ice before storage at −80 °C.
The resulting synaptosomal pellet was lysed and resus-
pended in 30 ml 6 mM Tris-HCl (pH 8.1) and centrifuged
at 11,800 g for 10 min. The supernatant was removed and
the pellet was again resuspended in 10 ml of 6 mM
Tris-HCl (pH 8.1) and recentrifuged at 8300 g for 10 min.
The supernatant was discarded and the pellet resuspended
in 10 ml of 3% Ficoll medium (3% Ficoll, 0.12 M mannitol,
30 mM sucrose, 25 μM K-EDTA, 5 mM Tris-HCl).
One third of this suspension was layered into 3 tubes
containing 5 ml 4.5% Ficoll medium (4.5% Ficoll, 0.24 M
mannitol, 60 mM sucrose, 50 μM K-EDTA, 10 mM
Tris-HCl) on top of 10 ml 6% Ficoll (6% Ficoll, 0.24 M
mannitol, 60 mM sucrose, 50 μM K-EDTA, 10 mM
Tris-HCl) and centrifuged at 11300 g for 30 min in a
swing-out Beckman ultracentrifuge. After centrifugation,
the top band was removed and the intermediate band
decanted and diluted with an equal volume of isolation
medium. This lysate was then centrifuged at 17,000 g for
10 min providing synaptosomally derived mitochondria
(SM population) and an SM2 fraction (pellet). The SM
and SM2 fractions were pooled to give a greater yield for
proteomic experiments and validation, frozen on dry ice
and stored at −80 °C.
Protein concentration assay
Samples were homogenized in label-free or RIPA buffer
+1% protease cocktail inhibitor (Thermo Scientific).
After homogenization, samples were centrifuged at
20,000 g for 20 min at 4 °C. The supernatant containing
the solubilized protein was removed and pellets dis-
carded. Protein concentration of samples was deter-
mined using a Pierce Micro BCA assay kit according to
the manufacturers instructions.
Label-free proteomics
Synaptic and non-synaptic mitochondrial preparations were
extracted in SDT lysis buffer containing 100 mM Tris-HCl
(pH 7.6), 4% (W/V) sodium dodecyl sulfate (VWR) and
0.1 M d/l-dithiothreitol (Sigma). For efficient protein ex-
traction, lysates were freeze–thawed and homogenized in
SDT buffer several times. Protein concentration was then
determined using BCA assay. Aliquots (2 mg) of each mito-
chondrial preparation were processed through FASP (filter-
aided sample preparation) involving buffer exchange to
8 M urea and alkylation with 50 mM iodoacetamide prior
to a double digestion with trypsin (Roche, sequencing
grade), initially overnight, then for an additional 5 h at 30 °
C. Resulting peptides were desalted then separated using an
Ultimate 3000 RSLC (Thermo Scientific) nanoflow LC sys-
tem. Using an ESI Easy Spray source at 50 °C, technical
replicates (3 × 0.75 μg) of each sample were loaded with a
constant flow of 5 μL/min onto an Acclaim PepMap100
nanoViper C18 trap column (100 μm inner diameter, 2 cm
length; Thermo Scientific). After trap enrichment for
3 min, peptides were eluted onto an Acclaim PepMap
RSLC nanoViper, C18 column (75 μm, 50 cm; Thermo
Scientific) with a linear gradient of 2–40% solvent B (80%
acetonitrile with 0.08% formic acid) over 90 min with a
constant flow of 300 nL/min. The HPLC system was
coupled to a linear ion trap Orbitrap hybrid mass spec-
trometer (LTQ-Orbitrap Velos Pro, Thermo Scientific) via
a nanoelectrospray ion source (Thermo Scientific). The
spray voltage was set to 1.6 kV, and the temperature of the
heated capillary was set to 250 °C. Full-scan MS survey
spectra (m/z 335–1800) in profile mode were acquired in
the Orbitrap with a resolution of 60,000 after accumula-
tion of 1,000,000 ions. The 15 most intense peptide ions
from the preview scan in the Orbitrap were fragmented by
collision-induced dissociation (normalized collision en-
ergy, 35%; activation Q, 0.250; and activation time, 10 ms)
in the LTQ after the accumulation of 10,000 ions. Dy-
namic exclusion parameters were set as follows: repeat
count, 1; repeat duration, 30 s; exclusion list size, 500; ex-
clusion duration, 45 s; exclusion mass width, plus/minus
10 ppm (relative to reference mass). Maximal filling times
were 1000 ms for the full scans and 150 ms for the MS/
MS scans. Precursor ion charge state screening was en-
abled, and all unassigned charge states as well as singly
charged species were rejected. The lock mass (445.120024),
option was enabled for survey scans to improve mass accur-
acy. Data were acquired using the Xcalibur software (for all
raw data see PRIDE project accession: PXD005537).
Raw proteomic data were imported into Progenesis for
characterization and analysis of relative ion abundance. 2D
representations of MS/MS output were created for each
sample and these were aligned to determine similar fea-
tures (average alignment score > 90%). Following align-
ment, data was filtered by retention time with features
detected below 5 min and above 110 min discarded to cor-
rect for elution variability and peptides with charge state
between 2 and 5 only included in the search. The runs
were grouped according to subcellular localization (synap-
tic and non-synaptic) and Statistical P values were auto-
matically generated in Progenesis software through a 1 way
ANOVA on the ArcSinh transform of the normalized data.
Peptides were filtered by the following criteria: power < 0.8,
fold change >2, p<0.05 and the remaining data were exported
from Progenesis for identification of individual peptide se-
quences using the Uniprot Swall subspecies Rattus
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norvegicus via Mascot Search Engine (V2.3.2). Enzyme speci-
ficity was set to that of trypsin, allowing for cleavage N-
terminal to proline residues. Other parameters used were as
follows. (i) Variable modifications: methionine oxidation, me-
thionine dioxidation, protein N-acetylation, gln → pyro-glu.
(ii) Fixed modifications: cysteine carbamidomethylation. (iii)
MS/MS tolerance: FTMS- 10 ppm, ITMS- 0.6 Da. (iv)
Maximum missed cleavages: 2. (vi) False Discovery Rate: 1%.
A cutoff score of >29 was used based on Mascot
probability threshold of 0.05 that the observed hit is
a random event. As an indication of identification
certainty, the false discovery rate for peptide matches
above identity threshold was set at 1%.
Identified proteins were re-imported into Progenesis
for further processing. Proteins were subject to stringent
filtering parameters to eliminate those which had <2
unique peptides, <2-fold change between subpopulations
and p>0.05 to obtain the proteins which demonstrated
the largest significant variation in expression between
synaptic and non-synaptic mitochondria. See Additional
file 1: Table S1 and Additional file 2: Table S2 for raw
unfiltered and filtered data respectively.
Ingenuity pathway analysis
IPA was performed as previously described [20] with the
interaction data limited as follows: direct and indirect inter-
actions; experimentally observed data only; 35 molecules per
network; 10 networks per dataset. Prediction activation
scores (z-score) were calculated in IPA. The z-score is a stat-
istical measure of the match between an expected relation-
ship direction and the observed protein expression. Positive
z-scores indicate activation (orange) and negative z-scores in-
dicate inhibition (blue) [21].
Quantitative fluorescent western blotting
Quantitative fluorescent western blotting was performed
as previously described [22]. Samples were diluted to
provide desired protein concentration. 10-15 μg protein
was loaded per well into Nu-PAGE® Novex® 4-12% Bis
Tris mini-gels (Life Technologies) and transferred to
PVDF membranes using an iBlot® and Invitrogen gel
transfer stacks. Membranes were incubated in primary
antibodies at 4 °C and secondary antibodies at room
temperature (concentrations according to manufacturers
instructions) before imaging on Li-COR Odyssey infra-
red scanner. Protein expression wasquantified utilising
ImageStudio Lite software (Li-COR Biosciences). Primary
antibodies: citrate synthase (OriGene, Cat. TA310356),
VDAC1 (Abcam, Cat. ab14734), telomerase (Abcam, Cat.
ab32020), HIBCH (Abcam Cat. ab101672), OGDH
(ProteinTech Cat: 15,212-1-AP), COXIV (Abcam Cat.
ab16056); secondary anitbodies: Goat anti-rabbit IRDye
680 (Odyssey), donkey anti-mouse IRDye 680 (Odyssey).
Transmission electron microscopy
Human mixed sex cortical samples (n = 4) from patients
without neurological phenotypes were prepared for elec-
tron microscopy as previously outlined in detail [23].
Briefly, fresh post-mortem samples, stored in 0.1 M PB
were trimmed into small cortical blocks and fixed in 4%
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M PB
for 48 h. Mouse brain samples were prepared as follows:
anesthetized WT male C57BL/6 J mice ((n = 4) intraper-
itoneal injection of Ketanest (100 mg/kg) and Rompun
(5 mg/kg)) were killed by perfusion fixation with 0.1 M
phosphate buffer containing 4% paraformaldehyde and
2.5% glutaraldehyde before removing the brain and im-
mersing it in fixative for a further 12 h. Following fix-
ation, both human and mouse brain samples were
washed in 0.1 m phosphate buffer before cutting free
floating 70-μm-thick coronal sections on a Vibratome.
Sections were postfixed in 1% osmium tetroxide in
0.1 m phosphate buffer for 45 min. Following dehydra-
tion through an ascending series of ethanol solutions
and propylene oxide, all sections were embedded on
glass slides in Durcupan resin. Regions of interest were
glued onto a resin block for sectioning. Ultrathin sec-
tions (60–70 nm) were cut and collected on Formvar-
coated grids (Agar Scientific), stained with uranyl acetate
and lead citrate in an LKB “Ultrostainer”, and then
quantitatively assessed in a Philips CM12 transmission
electron microscope. Negatives taken in the microscope
were scanned into an Apple Macintosh G5 computer
using an Epson 4870 Photo flat-bed scanner at 600dpi
and subsequently processed using Adobe Photoshop.
Images from 232 human and 270 murine slices were
analysed using the ImageJ measurements function.
Drosophila stocks
Flies were raised on standard cornmeal food at room
temperature. Homology of rat gene of interest and Dros-
ophila orthologue was determined by input into DIOPT
(DRSC Integrative Ortholog Prediction Tool [24]). Off-
target effects of candidate lines were assessed using
E-RNAi software [25]. Candidate lines exhibited no
off-target effects based on genetic mapping data and
all displayed 97.21-100% efficiency for targeting the
intended gene (Ndufb8 = 97.75%; mitofilin = 97.21%;
Vdac1 = 100%; Aldh = 100%). The elav-Gal4 driver strain
(Bloomington Drosophila stock center) was used for all
experiments. Stocks were obtained from the VDRC (IDs:
21,707, 47,615, 101,336, 30,413) and Bloomington Dros-
ophila stock center (Canton-S). Crosses were maintained
at 22 °C for 24 h before removal of adults and embryos
were incubated in a water bath at 30 °C to increase levels
and activity of the Gal4 proteins.
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Immunohistochemistry
Third instar larvae were selected and dissected in PBS
(n = 8). The dissected larval neuromuscular junctions
(NMJs) were fixed in Bouin’s fixative (15:5:1 picric acid,
37% formaldehyde and acetic acid) for 10 min and
washed thoroughly in PBT (PBS + 0.1% TritonX-100).
Preparations were blocked in PBT + 10% normal goat
serum for 2 h then incubated in primary antibody over-
night at 4 °C. NMJs were again washed extensively in
PBT and incubated in secondary antibody at room
temperature for 2 h. Samples were mounted on micro-
scope slides using Vectashield mounting medium (Vector
Laboratories) and imaged on a Zeiss confocal microscope.
Images were quantified using the Andlauer & Sigrist, 2012
protocol [26] in ImageJ. Briefly, segmented masks of the
fluorescent signal were generated for each channel and the
dimension and intensity of each particle was quantified.
Primary antibody: Horseradish peroxidase (HRP (1:200));
secondary antibody: anti-HRP goat biotinylated anti-rabbit
(1:400). All antibodies from Jackson ImmunoResearch.
Statistical analysis
Data were collected in Microsoft Excel and statistical tests
were performed in GraphPad Prism 6 software. For all ana-
lyses p<0.05 was considered statistically significant. Statis-
tical tests used are detailed in the results or figure legends
where appropriate.
Results
Mitochondrial subcellular localisation dictates organelle
morphology in rodents and humans
Enzymatic activity differences between neuronal mitochon-
drial sub-populations were first comprehensively described
in the 1970s [17]. However, the molecular underpinnings of
these biochemical differences and their morphological or
physiological consequences were never elucidated. We
therefore began by investigating whether mitochondria
residing at synaptic terminals were morphologically differ-
ent from those in non-synaptic compartments. It has previ-
ously been suggested that the size of mitochondria may
provide indications of biochemical processes as well as
neuronal integrity and survival. Numerous studies have
begun to describe mitochondrial morphology in the cell
body [10, 27–29] but few demonstrate characterisation of
those organelles in the axon and synapse – the compart-
ments that show heightened vulnerability to degenerative
insult. To establish whether size differences existed between
synaptic and non-synaptic mitochondria, we examined
transmission electron microscopy images from human and
mouse cortical tissue. Mitochondria were classified as ‘syn-
aptic’ if they were <1 μm from the post-synaptic density
and vesicles were clearly present within the presynaptic ter-
minal. Mitochondria outside of the pre- and postsynaptic
boutons were classed as non-synaptic; anything ambiguous
was excluded from the analysis. The results indicate that in
both mouse and human cortex, non-synaptic mitochondria
appear significantly larger than the organelles present
within synaptic terminals ((Fig. 1) mouse: p<0.0001; human:
p=0.0099, respectively). Non-synaptic populations in both
species demonstrated elongation versus that of synaptic
mitochondria, which displayed a spherical morphology
(data not shown). Although these morphological differences
between mitochondrial sub-populations may solely reflect
adaptations to the particular size and structure of cellular
compartments, we hypothesised that biochemical adapta-
tions would also likely exist due to the dynamic interplay
between protein expression and organelle configuration
(see Picard et al., 2013 for a comprehensive review on mito-
chondrial morphology and function [30]).
Label-free proteomics reveals significant mitochondrial
heterogeneity
To identify molecular differences between mitochondria
derived from synaptic and non-synaptic neuronal com-
partments, we performed label-free proteomics on
mitochondrial-enriched fractions isolated from rat fore-
brain. Quantitative label-free proteomic analyses identi-
fied >1500 proteins associated with both synaptic and
non-synaptic mitochondria, revealing dynamic variations
in protein expression dependent upon subcellular local-
isation (Fig. 2a and b). Strikingly, over 400 proteins were
altered by greater than 2-fold between mitochondrial
subpopulations (Fig. 2c), demonstrating significant
compartment-dependent biochemical adaptations.
Relative purity of mitochondrial isolates was verified
using bioinformatics (Table 1), quantitative enrichment
analyses utilizing the raw proteomic data and quantitative
fluorescent western blotting (QFWB) on ovine forebrain.
The mitochondrial yield obtained from rat forebrain was
not sufficient for validation purposes (see methods). The
mitochondrial markers VDAC1 and COXIV indicated sig-
nificant enrichment in synaptic and non-synaptic mito-
chondrial fractions versus whole brain lysate suggesting
purification of the mitochondria from their respective sub-
cellular compartments (Fig. 3a). To demonstrate the purifica-
tion of mitochondria from discrete neuronal compartments,
we calculated the normalised average abundance of the well-
established synaptic markers Snap25, Synaptopodin (Synpo),
Synaptojanin-1 (Synj1) and Psd3 for both the synaptic and
non-synaptic mitochondrial preparations. Indeed, expression
levels of Snap25, Synpo, Synj1 and Psd3 indicated significant
enrichment in synaptic mitochondrial preparations versus
non-synaptic suggesting purification of synaptically derived
mitochondria (Fig. 3c). In addition to demonstrating purifica-
tion of mitochondrial subpopulations, we again employed
QFWB to determine the veracity of the proteomic data. We
observed corresponding protein expression trends in each
tissue preparation, as indicated by the proteomics, for
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multiple proteins (Fig. 3d-f). Taken together, these results in-
dicate the relative purity of the mitochondrial isolates and
suggest the proteomic data is representative of the molecular
alterations occurring in the tissue samples. Furthermore, the
data indicate that the observed heterogeneity in mitochon-
drial protein expression may be conserved between mamma-
lian species.
Expression profiling highlights bioenergetic alterations
between synaptic and non-synaptic mitochondrial
proteomes
Having confirmed the veracity of the proteomic data, we
next sought to further dissect the proteomic data using
Biolayout Express3D [31]. The software applies unbiased
Markov clustering algorithms to the input data and groups
proteins displaying similar expression trends. This allows
visualisation of spatial profiles promoting the identification
of physiological cascades altered within the dataset. The
nodes, shown as spheres with identical dimensions, signify
individual proteins and the edges, represented by connect-
ing lines, are indicative of the correlation of protein expres-
sion within the data. Graphs were constructed in 3D space
utilizing the 1511 identified proteins from the mitochon-
drial proteomic analysis (see Fig. 2b and c), generating 10
protein clusters. In agreement with the principal compo-
nent analysis correlation graphs (Fig. 2d and e), network
clustering of the data displayed similar trends with regards
to fragmentation of the graph into two localisation-
dependent networks (Fig. 4). The fragmentation of the
dataset into 2 distinct groups suggests that significant
heterogeneity in protein expression exists between the
mitochondrial populations derived from discrete neuronal
sub-compartments. Indeed, with further examination we
exhibited that proteins with increased abundance in synap-
tic mitochondria cluster into the distinct network on the
left of the graph whereas those with increased abundance
in non-synaptic mitochondria are observed in the right net-
work (Fig. 4). To identify the functional cascades associated
Fig. 1 Synaptic and non-synaptic mitochondria are morphologically distinct in both rodent and human brain tissue. a and b. Example EM images of WT
mouse and human cortical tissue displaying synaptic and non-synaptic mitochondria (S = synaptic, NS = non-synaptic). c and d. Scatterplots representing WT
mouse (c.) and control human patient (d.) cortical synaptic and non-synaptic mitochondrial normalized areas (c. synaptic n = 391, non-synaptic n = 1113 from 4
mice; d. synaptic n = 177, non-synaptic n = 812 from 3 patients). A data point of distinct shape represents each individual animal or patient. Non-synaptic
mitochondria appear to be significantly larger than synaptic mitochondria in both mouse and human cortical tissue. Statistical analyses used unpaired two-tailed
Student’s t-tests with Welch correction for unequal sample size: ****p<0.0001, **p<0.01). Scale bars = 0.5 μm
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Fig. 2 Identification of the mitochondrial proteome. a. 2-way clustering of 1511 proteins identified in both synaptic (S) and non-synaptic (NS) mitochondrial
samples. Each column represents a single LC-MS/MS run, based on log-transformed data. Proteins (rows) and samples (columns) are clustered by similarities in
protein expression intensity, represented by the colour range: dark blue = least abundant, to dark red = most abundant. Dendrogram indicates protein
expression differences between synaptic and non-synaptic mitochondrial sub-populations in addition to grouping of individual proteins that demonstrate
similar intensity profiles. b. Graph represents expression of all 1511 identified proteins with 2 or more unique peptides, independent of magnitude. c. Graph
displays the 411 proteins which have a > 2 fold change between populations, p < 0.05 and were identified with >1 unique peptide. The expression profile
demonstrates 2 clear trends of differential protein expression between the sub-populations of mitochondria: proteins that are more abundant in synaptic
mitochondria and less abundant in non-synaptic, and vice-versa. d and e. Principal components analyses of the unfiltered (d) and filtered (e) proteomic
data. Pink data points denote non-synaptic mitochondrial samples and blue data points indicate synaptic mitochondrial samples. Samples are clustered by
subcellular localization in both the filtered and unfiltered datasets with little technical variation. Grey displays identified proteins by accession number
Table 1 DAVID 6.7 (NIAID/NIH) enrichment analysis of synaptic and non-synaptic mitochondrial samples. Table comprises the top
gene ontology (GO) terms associated with 1511 proteins identified in synaptic and non-synaptic mitochondrial samples. The analysis
displays predominantly mitochondrial components, suggesting the samples are enriched for mitochondria
Annotation Enrichment Score 36.31 Count P_Value Fold Change Benjamini
GOTERM_CC_FAT Mitochondrion 231 2.50E-61 3.00E + 00 1.20E-58
GOTERM_CC_FAT Mitochondrial part 138 4.50E-54 4.40E + 00 1.10E-51
GOTERM_CC_FAT Mitochondrial membrane 109 1.70E-47 5.00E + 00 2.60E-45
GOTERM_CC_FAT Mitochondrial envelope 111 4.20E-46 4.70E + 00 5.00E-44
GOTERM_CC_FAT Mitochondrial inner membrane 93 7.40E-44 5.40E + 00 7.10E-42
GOTERM_CC_FAT Organelle inner membrane 94 3.20E-42 5.20E + 00 2.50E-40
GOTERM_CC_FAT Organelle membrane 164 4.80E-38 2.90E + 00 3.30E-36
GOTERM_CC_FAT Organelle envelope 118 1.10E-35 3.60E + 00 6.50E.34
GOTERM_CC_FAT Envelope 118 2.30E-35 3.50E + 00 1.20E-33
KEGG_PATHWAY Oxidative phosphorylation 57 2.10E-31 6.20E + 00 3.00E-29
SP_PIR_KEYWORDS Mitochondrion 104 6.80E-30 3.40E + 00 9.70E-28
KEGG_PATHWAY Parkinson’s disease 54 2.10E-27 5.70E + 00 1.50E-25
KEGG_PATHWAY Huntington’s disease 59 1.00E-24 4.70E + 00 4.90E-23
KEGG_PATHWAY Alzheimer’s disease 58 5.40E-23 4.40E + 00 1.90E-21
SP_PIR_KEYWORDS Mitochondrial inner membrane 35 6.40E-15 4.80E + 00 2.70E-13
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Fig. 3 Purification of distinct mitochondrial subpopulations and validation of proteomic data. a. Quantitative fluorescent western blots demonstrating
relative abundance of the mitochondrial markers COXIV and VDAC1 and the nuclear marker telomerase in whole brain lysate and mitochondrial samples.
Mitochondrial samples display little nuclear contamination and enrichment of COXIV and VDAC1. b. Quantification of the beta-tubulin loading control signal.
c. Purity of mitochondrial isolates was verified with quantitative enrichment analyses utilising the raw proteomic data. Comparative expression of the synaptic
markers Snap25, Synpo, Synj1 and Psd3 indicate significant enrichment (****p<0.0001) of the proteins in synaptic mitochondrial preparations. d-f. Left bar chart
displays the proteomic average normalised expression values of proteins in synaptic and non-synaptic mitochondria. Right bar chart demonstrates sample
protein expression quantified by fluorescent western blots. Proteomic and sample expression of all proteins (HIBCH, OGDH and citrate synthase) follow the same
trend thereby providing validation of the proteomic data. Statistical analyses utilized unpaired two-tailed Student’s t-test, n = 3 (** p=<0.01; *** p=<0.001;
**** p=<0.0001)
Fig. 4 Expression profile clustering identifies alterations associated with bioenergetic control. Nodes (spheres) represent individual proteins and edges
(lines) reflect the strength of correlation of expression between proteins. The schematic displays 2 distinct protein networks – proteins displaying
increased abundance in synaptic mitochondria on the left and those exhibiting enhanced expression in non-synaptic mitochondria on the right.
Coloured nodes represent protein clusters based on expression profile and each cluster displays their representative functions determined by DAVID.
Graph clustered by Pearson r = 0.98
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that appear to demonstrate differential expression between
the two mitochondrial subpopulations, the top 3 protein
clusters were entered into Database for Annotation,
Visualization and Integrated Discovery (DAVID) v6.7 to de-
termine the basic functions of the clustered proteins
(Fig. 4). Interestingly, the proteins that exhibit upregu-
lation in synaptic mitochondria (clusters 1 and 2) are asso-
ciated with the inner membrane bioenergetic complexes,
which suggests that distinct synaptic and non-synaptic
mitochondrial protein expression may reflect altered local
Fig. 5 Pathway analysis highlights mitochondrial alterations associated with altered synaptic function and a broad range of neurodegenerative
diseases, mediated by complex 1. a. 411 differentially expressed mitochondrial proteins are implicated in the literature as contributors to
neurological disease, psychological disorders and skeletal and muscular disorders. b. Mitochondrial complex 1 is central to the network of
interactions (highlighted in light blue) and features a number of intrinsic mitochondrial proteins and 2 protein families. Expression of the synaptic
mitochondrial proteome is associated with perturbed synaptic structure and function. c. The significant differential expression of proteins in
synaptic and non-synaptic compartments appears to inhibit downstream pathways associated with synaptic transmission. Solid lines indicate direct
interactions; dashed lines represent indirect interactions; proteins highlighted in pink are those which are more abundant in synaptic mitochondria;
proteins in green are those which are more abundant in non-synaptic mitochondria; dark blue represents predicted pathway inhibition. Shapes are
indicative of protein function: diamond = enzyme; rectangle = GPCR; square = cytokine; trapezoid = transporter; circle = other
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requirements for energetic expenditure. Interestingly, these
data correlate with the original biochemical study by Lai et
al. [17], which reported variations in mitochondrial enzym-
atic activities dependent upon the subcellular localisation of
the organelles. Here, we can account for approximately
35% of those reported enzymatic activity alterations, which
are likely due to the differing abundance of particular en-
zymes in the discrete sub-pools of mitochondria.
Pathway analysis highlights mitochondrial complex I
expression differences as potentially conserved regulators
in a range of neurodegenerative conditions
In order to determine how differential protein expres-
sion in mitochondrial subpopulations may synergistic-
ally regulate downstream molecular pathways and
cellular processes, we performed an in silico analysis
using Ingenuity Pathway Analysis (IPA) software. The
software promotes the identification of statistically
significant functional groups of proteins, based on
known protein interactions and biological functions
reported in the published literature [20]. Functional
networks generated by IPA software are statistically
ranked according to a score calculated via a right-
tailed Fischer’s exact test, taking into account the
number of original input proteins and the size of the
resulting network. With input of the 411 differentially
expressed proteins from the mitochondrial proteomic
data (>2-fold change), the analysis revealed that 154
(37%) candidates have previously been associated with
neurological diseases in the published literature
(Fig. 5a), suggesting that a multitude of these proteins
may play a role in regulating synaptic stability.
Further examination into the molecular cascades that may
be associated the pathogenesis of neurodegenerative diseases
highlights that mitochondrial complex I is an upstream regu-
lator of degenerative processes (Fig. 5b). The particular ex-
pression of proteins downstream of complex I in synaptic,
but not non-synaptic, mitochondria have previously been im-
plicated in numerous neurodegenerative diseases including
Huntington’s disease, Parkinson’s disease and Lewy body de-
mentia - all of which demonstrate synaptic perturbations
early during pathogenesis (for a comprehensive review see
[1]). These results suggest that modulation of the synaptic
mitochondrial proteome may synergistically drive the demise
of the synapse in age-related neuropathologies. In conjunc-
tion, assessment of the downstream physiological cascades
modulated by synaptic mitochondrial protein expression
identified significant inhibition of synaptic transmission cas-
cades (Fig 5c). The increased expression of alpha-synuclein,
GAD1, SH3GL1, SH3GL2, S100B PPP3R1 and SYT1 in the
non-synaptic mitochondrial proteome appears to indirectly
inhibit synaptic transmission. Conversely, the enhanced ex-
pression of SNPH, PRNP, GNAI1 and GNAI2 in synaptic
mitochondria inhibits neurotransmission cascades in the
synaptic compartment. This suggests that heterogeneity in
discrete mitochondrial proteomes and their associated down-
stream pathways has the propensity to promote functional
alterations at the synaptic terminal.
Mitochondrial proteins regulate synaptic morphology in
vivo
Although we had generated a compendium of the mo-
lecular differences present between synaptic and non-
synaptic mitochondrial populations, it remained unclear
if any of the identified proteins were capable of actively
modulating synaptic stability in vivo. To assess this, we
employed a molecular genetic approach using the Drosophila
larval neuromuscular junction (NMJ) to screen individual
proteins to examine their potential role in regulating synaptic
morphology. The larval NMJ is an excellent model system to
unravel the molecular mechanisms underpinning synaptic
structure, function and plasticity [32]. Fundamental mamma-
lian biological and neurological pathways demonstrate con-
servation in Drosophila and recent evidence has indicated
that up to 75% of human disease related genes exhibit a
functional orthologue in the fruit fly [33]. Larval NMJs
harbour glutamatergic synaptic boutons with contiguous in-
vaginated post-synaptic membranes [34, 35], which display
significant homology to those found in the mammalian cen-
tral nervous system. Neurotransmission between these con-
nections has the propensity to invoke plastic modifications
[32, 34, 36], providing physiologically relevant mechanistic
insights into proteins regulating the structure and function
of the synapse in mammalian cognition [36].
In order to assess whether the expression of particular
proteins in synaptic mitochondria may be regulating the
morphology of the synapse, we utilised the Drosophila
UAS/Gal4 system, which allows tissue specific expres-
sion of a particular transgene with use of selected drivers
[37]. We selected candidates based on magnitude of
change, mitochondrial localisation and availability of
Drosophila orthologues (see Table 2). Interestingly, the
short-listed candidates displayed increased protein ex-
pression in synaptic versus non-synaptic mitochondria.
Thus, we aimed to selectively knock-down the
Table 2 Diopt homology score for Drosophila lines employed
in all experiments. Scores demonstrate the degree of homology
between the rat gene of interest and equivalent Drosophila
orthologue. A score of >2 is considered sufficiently
homologous. Scores range from 1 to 11
Gene Fly Gene Stock Diopt Score Magnitude of Change
Ndufb8 CG3192 v30413 8 2.04
Mitofilin CG6455 v47615 6 1.9
Vdac1 CG6647 v101336 7 2.23
Aldh CG3752 v21707 5 3.29
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expression of these mitochondrial proteins in third instar
larva neurons for assessment of associated phenotypes. Pan-
neural expression of the RNAi constructs (v30413; v47616;
v10136; v21707) under control of the elav-Gal4 driver re-
sulted in viable larva from all crosses. To assess synaptic
morphology and potential mitochondrial-dependent alter-
ations in synaptic transmission, we examined the larval
muscle 12/13 NMJ by immunohistochemistry with anti-
bodies against the presynaptic marker horseradish peroxid-
ase (HRP) and active zone marker bruchpilot (BRP). Here,
we found that the selective RNAi-mediated knock-down of
single candidates produced striking synaptic phenotypes at
the NMJ (Fig. 6). NDUFB8, mitofilin, VDAC1 and ALDH
demonstrated varied phenotypes at the NMJ with alter-
ations in distinct synaptic parameters including bouton
diameter and total bouton area (Fig. 6). The most severe
phenotype was associated with selective knock-down of al-
dehyde dehydrogenase (ALDH), which promoted signifi-
cant reductions (p<0.05) in synaptic bouton area with
concomitant loss of distinguishable Ib and Is boutons (Fig.
6a). In conjunction, there was a significant decrease
(p<0.0001) in synaptic bouton active zone staining (Fig. 7a)
relative to control NMJs. Similarly, knock-down of neur-
onal NDUFB8 expression promoted aberrant NMJ morph-
ology (Fig. 6a and b) with significant increases in bouton
diameter. Despite this, the NMJs demonstrated a corre-
sponding reduction in active zone area (p<0.0001) versus
controls (Fig. 7a and c). Interestingly, we did not observe
any obvious perturbations in axonal branching or morph-
ology in our elav-Gal4/RNAi lines (Fig. 6f and g), suggest-
ing that selective knock-down of these candidates promotes
selective alterations in synaptic morphology, mediated by
mitochondrial protein expression. Significant reductions in
the area of active zone staining in both the ALDH and
NDUFB8 RNAi lines suggests that mitochondria may have
a direct functional impact on vesicular release and bouton
firing properties. Although the mechanistic pathways
modulating these alterations remain elusive, regulation of
the mitochondrial proteome appears to be significant me-
diator of synaptic-specific structural and biochemical
properties.
Discussion
The current study has demonstrated novel insights into
how a ‘top-down’ approach may be utilised for identifying
individual proteins that may modulate the stability of syn-
aptic compartments in vivo. By using a range of techniques
we have shown that neuronal mitochondria derived from
synaptic and non-synaptic cellular compartments display
significant morphological and biochemical differences. Elec-
tron microscopy analyses from mouse and human cortical
tissue suggest that non-synaptic mitochondria are signifi-
cantly larger than those found in the synaptic terminal.
Alongside these morphological alterations, we have also
demonstrated that upwards of 400 mitochondrial associ-
ated proteins identified from our label-free proteomic ex-
periments display a ≥ 2-fold expression difference between
sub-populations. Using molecular genetic tools at the Dros-
ophila neuromuscular junction, we were able to manipulate
the expression of 4 of the identified candidates that dis-
played increased abundance in synaptic mitochondria,
resulting in selective alterations in synaptic, but not obvious
axonal morphology in vivo. Our data promote further un-
derstanding of the basic biology of the mitochondria and
how these organelles may regulate the vulnerability of the
synapse in a physiologically relevant model. In addition, the
results presented may provide increased insight into how
mitochondrial perturbations influence the synaptic alter-
ations commonly occurring during ageing and disease.
Our initial proteomic screen revealed a remarkably large
and heterogeneous list of candidates that significantly dif-
fered in expression dependent upon mitochondrial subcel-
lular localisation. Despite this heterogeneity, upon further
analysis of the data utilising in silico tools, it became ap-
parent that many of these proteins have previously been
associated with perturbations in synaptic transmission.
Experimental manipulation of 4 of these candidates pro-
duced varied synaptic phenotypes. The differing morpho-
logical phenotypes likely reflect the functional specificities,
biological roles and downstream cascades associated with
the proteins. NDUFB8, a mitochondrial complex I sub-
unit, produced a relatively mild phenotype at the NMJ
with morphological overgrowth but retention of branch-
ing patterns seen in controls. The preservation of numer-
ous morphological characteristics despite NDUFB8
knock-down may reflect a compensatory mechanism oc-
curring within the elaborate multi-subunit complex I.
Conversely, reductions in ALDH expression resulted in
the most severe phenotype, with significant alterations in
synaptic bouton morphology and striking alterations
within the NMJ architecture. This is likely due to its pri-
mary role in protecting mitochondria from endogenous
aldehydes generated by lipid peroxidation [38]. With re-
ductions in ALDH, it is probable that an accumulation of
noxious metabolites occurs, resulting in cytotoxicity. In
support of our observations, a previous study from our la-
boratory [39] reported that Drosophila harbouring mutant
ALDH displayed spontaneous degeneration of axons in
the olfactory receptor neuron, however the presence of a
synaptic phenotype was not morphologically assessed in
that system. Furthermore, there have been several recent
reports documenting a potential detoxification role for
ALDH specifically in populations of dopaminergic neu-
rons [40]. Notably, sub-populations of dopaminergic cells
from the brains of Parkinson’s disease patients demon-
strated a significant reduction in ALDH [41], which may
contribute to alterations in synaptic stability resulting in
the activation of degenerative cascades.
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Fig. 6 (See legend on next page.)
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Despite NDUFB8 and ALDH demonstrating varied
synaptic bouton phenotypes, both candidates promoted
a significant reduction in the active zone area. Mito-
chondrial morphology and function has been associated
with alterations in the efficacy of the presynaptic active
zone in numerous investigations, however the molecular
mediators regulating such events remain elusive. Synap-
tic transmission is a bioenergetically demanding process
requiring the persistent aerobic production of ATP and
buffering of intracellular Ca2+ concentrations. Evidence
indicates that mitochondria redistribute and bind to the
active zone in response to synaptic transmission for
homeostatic regulation at the synapse [42, 43], promot-
ing the controlled exocytosis underpinning neurotrans-
mission. Disruptions in the mitochondrial proteome may
have the propensity to alter the functional organisation
and stability of the active zone by reductions in calcium
buffering, ATP availability and/or vesicular endocytosis.
Although we directly manipulated the expression of
NDUFB8 and ALDH, it is likely that the NMJ mitochon-
dria harboured further disruptions to the proteome that
were hierarchically driven by alterations in the candi-
dates, which may have synergistically promoted aberra-
tions at the active zone.
Although a conventional RNAi screen would require
multiple RNAi and point mutations to be certain of the
importance of specific candidates, we have presented
several novel synaptic specific phenotypes with selective
knock-down of single mitochondrial candidates. How-
ever, it is unlikely that the differential expression of all of
these proteins can solely regulate synaptic morphology
and stability. Instead, it is probable that multiple cellular
and molecular pathways, up-and downstream of the
mitochondria, converge to modulate compartmental sta-
bility in mammalian systems. Thus, differentially
expressed mitochondrial candidates and/or their down-
stream cascades warrant further in vivo investigation to
examine the nature and extent of their role in the
modulation of synaptic architecture. Despite this,
protein expression within the mitochondria, as well as
the subcellular localisation of the organelle, are clearly
important variables that must be considered when char-
acterising cascades negatively affecting synaptic morph-
ology, transmission and physiology.
A next logical step in determining how the mitochon-
drial proteome may be contributing to synaptic vulner-
ability in vivo, is to perform an ageing study using the
same tools and techniques presented in the current in-
vestigation. It has been well documented that mitochon-
dria dynamically alter dependent on their environment
[10, 17–19], and we have provided further evidence for
this hypothesis here. However, few studies have
attempted to investigate how the synaptic mitochondrial
proteome alters during ageing and how variations in
protein expression may impact on the function and
architecture of the synapse in a physiologically relevant
model. An examination of such processes provides scope
to potentially identify mitochondrial proteins that may
be contributing to synaptic demise during normal
healthy and pathological ageing. Furthermore, these data
may indicate why such large disparities appear to exist
with regards to the vulnerability of synaptic and neur-
onal populations with different pathogenic insults.
Although the use of label-free proteomics has provided a
fairly comprehensive coverage of the mitochondrial prote-
ome (this study yields the highest identification of mitochon-
drial proteins in a single in vivo analysis to date (1511)), for
improved detection of low molecular weight proteins other
techniques such as tandem mass tagging with high fraction-
ation may be employed for future experiments. It is highly
likely that numerous mitochondrial proteins that were not
detected or removed from the data due to stringent filtering
parameters, may influence synaptic stability in vivo. Despite
this, it is abundantly clear that proteomics and molecular
genetics are powerful tools to identify candidates that may
impact upon synaptic structure and function.
(See figure on previous page.)
Fig. 6 Mitochondrial candidates modulate synaptic morphology in vivo. a. Representative image of WT muscle 12 NMJ in abdominal segment A3 (n = 8)
immunostained with anti-HRP. b-e. Top panel displays representative images of muscle 12 NMJ, hemisegment A3 bouton morphology with candidate knock-
down. Middle panel demonstrates masks utilized for quantification in ImageJ. Lower panel shows a section of axon. Scale bar = 10um for synaptic HRP and
mask layers, 5um for axons. b. elav-GAL4/Ndufb8RNAi; c. elav-GAL4/MitofilinRNAi; d. elav-GAL4/Vdac1RNAi; e. elav-GAL4/AldhRNAi. Arrows represent loss or
alteration of boutons and/or fragmentation of dendritic branches. A variety of phenotypes exist. All NMJs immunostained with anti-HRP and imaged at 63×
(n = 8). f. Quantification of axon diameter in candidate lines versus control (Control mean ± SEM = 1.88 ± 0.02; Ndufb8 p=0.4095, mean ± SEM = 2.19 ± 0.26;
Mitofilin p=0.169, mean ± SEM = 1.52 ± 0.05; Vdac1 p=0.1427, mean ± SEM = 1.52 ± 0.15; Aldh p=0.3138, mean ± SEM = 2.28 ± 0.26). g. Quantification of
number of NMJ branches in candidate lines versus control (Control mean ± SEM = 6.0 ± 0.0; Ndufb8 p=0.1161, mean ± SEM = 6.66 ± 0.33; Mitofilin p=0.117,
mean ± SEM = 5.33 ± 0.33; Vdac1 p=0.2722, mean ± SEM = 5.5 ± 0.5; Aldh p=0.0522, mean ± SEM = 5.0 ± 0.0). h. Quantification of the synaptic bouton
diameter in candidate lines versus control (Control mean ± SEM = 1.95 ± 0.06; Ndufb8 p=0.0003, mean ± SEM = 2.43 ± 0.1; Mitofilin p=0.5759,
mean ± SEM = 2.02 ± 0.09; Vdac1 p=0.0003, mean ± SEM = 2.51 ± 0.15; Aldh p=0.5291, mean ± SEM = 1.87 ± 0.1). i. Quantification of the total bouton area in
candidate versus control lines (Control mean ± SEM = 5.08 ± 0.47; Ndufb8 p=0.4246, mean ± SEM = 4.57 ± 0.44; Mitofilin p=0.0078, mean ± SEM = 3.3 ± 0.23;
Vdac1 p=0.6083, mean ± SEM = 4.68 ± 0.47; Aldh p=0.0337, mean ± SEM = 3.6 ± 0.46). All quantification used students t-test; * = p<0.05, ** = p<0.01,
*** = p<0.001, **** = p<0.0001
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Conclusions
The current study has demonstrated novel insights into
how a ‘top-down’ approach may be utilised for identifying
novel candidates that may modulate the stability of synap-
tic compartments in vivo. Our investigation has estab-
lished that the morphological and biochemical properties
of synaptic and non-synaptic mitochondria differ signifi-
cantly across a multitude of mammalian species. Using
molecular genetic tools at the Drosophila neuromuscular
junction, manipulation in the expression several candi-
dates that displayed increased abundance in synaptic
mitochondria, resulted in selective alterations in synaptic,
but not axonal morphology in vivo. Thus changes in mito-
chondrial protein expression may contribute to increased
synaptic vulnerability in early molecular pathological pro-
cesses during ageing and/or disease.
Additional files
Additional file 1: Table S1. All proteins identified from synaptic and
non-synaptic mitochondrial proteomic analyses. (XLSX 273 kb)
Additional file 2: Table S2. All proteins identified from synaptic and
non-synaptic mitochondrial proteomic analyses with >2 fold-change,
p≥0.05, ≥2 unique peptides. (XLSX 106 kb)
Fig. 7 Manipulation of the mitochondrial proteome modulates active zone expression. a. Representative images of WT, NDUFB8 and ALDH muscle 12
NMJs from abdominal segment A3 (n = 8) immunostained with anti-HRP and anti-bruchpilot. Bottom panel displays ImageJ quantification mask utilized
for HRP staining. b. Quantification of total bouton area in NDUFB8 and ALDH RNAi lines (as displayed in Fig. 6i). c. Quantification of total NMJ active zone
area in NDUFB8 and ALDH RNAi lines (Control mean ± SEM = 0.87 ± 0.04; Ndufb8 p<0.0001, mean ± SEM = 0.62 ± 0.03; Aldh p<0.0001,
mean ± SEM = 0.64 ± 0.04. All quantification used students t-test (n = 8); * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Scale bar = 10um
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